Patents Assigned to Freenome Holdings, Inc.
  • Patent number: 11847532
    Abstract: Systems and methods that analyze blood-based cancer diagnostic tests using multiple classes of molecules are described. The system uses machine learning (ML) to analyze multiple analytes, for example cell-free DNA, cell-free microRNA, and circulating proteins, from a biological sample. The system can use multiple assays, e.g., whole-genome sequencing, whole-genome bisulfite sequencing or EM-seq, small-RNA sequencing, and quantitative immunoassay. This can increase the sensitivity and specificity of diagnostics by exploiting independent information between signals. During operation, the system receives a biological sample, and separates a plurality of molecule classes from the sample. For a plurality of assays, the system identifies feature sets to input to a machine learning model. The system performs an assay on each molecule class and forms a feature vector from the measured values.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: December 19, 2023
    Assignee: Freenome Holdings, Inc.
    Inventors: Adam Drake, Daniel Delubac, Katherine Niehaus, Eric Ariazi, Imran Haque, Tzu-Yu Liu, Nathan Wan, Ajay Kannan, Brandon White
  • Patent number: 11781959
    Abstract: The present disclosure provides methods and devices for sample extraction.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: October 10, 2023
    Assignee: FREENOME HOLDINGS, INC.
    Inventor: Daniel Delubac
  • Patent number: 11681953
    Abstract: Systems and methods that analyze blood-based cancer diagnostic tests using multiple classes of molecules are described. The system uses machine learning (ML) to analyze multiple analytes, for example cell-free DNA, cell-free microRNA, and circulating proteins, from a biological sample. The system can use multiple assays, e.g., whole-genome sequencing, whole-genome bisulfite sequencing or EM-seq, small-RNA sequencing, and quantitative immunoassay. This can increase the sensitivity and specificity of diagnostics by exploiting independent information between signals. During operation, the system receives a biological sample, and separates a plurality of molecule classes from the sample. For a plurality of assays, the system identifies feature sets to input to a machine learning model. The system performs an assay on each molecule class and forms a feature vector from the measured values.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: June 20, 2023
    Assignee: Freenome Holdings, Inc.
    Inventors: Adam Drake, Daniel Delubac, Katherine Niehaus, Eric Ariazi, Imran Haque, Tzu-Yu Liu, Nathan Wan, Ajay Kannan, Brandon White
  • Patent number: 11514289
    Abstract: Systems, methods, and apparatuses for generating and using machine learning models using genetic data. A set of input features for training the machine learning model can be identified and used to train the model based on training samples, e.g., for which one or more labels are known. As examples, the input features can include aligned variables (e.g., derived from sequences aligned to a population level or individual references) and/or non-aligned variables (e.g., sequence content). The features can be classified into different groups based on the underlying genetic data or intermediate values resulting from a processing of the underlying genetic data. Features can be selected from a feature space for creating a feature vector for training a model. The selection and creation of feature vectors can be performed iteratively to train many models as part of a search for optimal features and an optimal model.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: November 29, 2022
    Assignee: Freenome Holdings, Inc.
    Inventors: Gabriel Otte, Charles Roberts, Adam Drake, Riley Charles Ennis